|
2026 Journal Article KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non–Small Cell Lung CancerJabbour, Salma K., Sótér, Szabolcs, Eaton, Michael, Gálffy, Gabriella, Kowalski, Dariusz, Hata, Akito, Valdivia, Augusto, Frost, Nikolaj, Levchenko, Evgeny, Monteiro, Mariana, Haridass, Anoop, Bouchard, Myriam, Lee, Ki Hyeong, Ahn, Myung-Ju, Hughes, Brett G.M., Durham, André, Xu, Yan, Samkari, Ayman, Song, Andrew and Pircher, Andreas (2026). KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non–Small Cell Lung Cancer. Journal of Clinical Oncology JCO-26-00404. doi: 10.1200/jco-26-00404 |
|
2026 Journal Article Phase II Study of Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous Cell Carcinoma: Final AnalysisGross, Neil D., Miller, David M., Khushalani, Nikhil I., Divi, Vasu, Ruiz, Emily S., Lipson, Evan J., Meier, Friedegund, Su, Yungpo Bernard, Swiecicki, Paul L., Atlas, Jennifer, Geiger, Jessica L., Hauschild, Axel, Choe, Jennifer Hsing, Hughes, Brett G.M., Lim, Annette M., Ferrarotto, Renata, Wang, Bei, Tao, Weiwei, Brennan, Laura, Yoo, Suk-Young, Seebach, Frank, Lowy, Israel, Mathias, Melissa, Han, Hyunsil, Fury, Matthew G. and Rischin, Danny (2026). Phase II Study of Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous Cell Carcinoma: Final Analysis. Journal of Clinical Oncology JCO-26-02166. doi: 10.1200/jco-26-02166 |
|
2026 Journal Article Longitudinal liquid biopsy alongside positron emission tomography‐computed tomography surveillance in p16‐positive oropharyngeal squamous cell carcinoma: A translational case studyDamodaran, Sreedevi, Weeramange, Chameera Ekanayake, Kenny, Lizbeth, Vasani, Sarju, Breik, Omar, Taheri, Touraj, Leo, Paul, Hughes, Brett G. M. and Punyadeera, Chamindie (2026). Longitudinal liquid biopsy alongside positron emission tomography‐computed tomography surveillance in p16‐positive oropharyngeal squamous cell carcinoma: A translational case study. Clinical and Translational Discovery, 6 (5) e70220, 5. doi: 10.1002/ctd2.70220 |
|
2026 Journal Article Skull base surgery: a patient-centred perspective on care and recoveryHiatt, Joanne, Brown, Teresa, Sommerville, Ryan, Gan, Richard, Walker, Abigail, Burns, Clare, Moroney, Laura, Hughes, Brett and Bauer, Judy (2026). Skull Base Surgery: A Patient-Centred Perspective on Care and Recovery. Journal of Neurological Surgery Part B: Skull Base. doi: 10.1055/a-2928-4058 |
|
2026 Journal Article Survival and toxicity in elderly patients treated with chemoradiotherapy for head and neck cancer: a retrospective study at a large quaternary centreSekar, Prasanth, Goetz, Julika, Ng, Gary, Nottage, Michelle and Hughes, Brett G. M. (2026). Survival and toxicity in elderly patients treated with chemoradiotherapy for head and neck cancer: a retrospective study at a large quaternary centre. Clinical Oncology, 56 104191, 1-10. doi: 10.1016/j.clon.2026.104191 |
|
2026 Journal Article A prospective study of definitive ChemoRadiation with ImmunOtherapy (CRIO) in locally or regionally advanced, unresectable cutaneous squamous cell carcinomaLin, Charles, Ng, Gary, Nottage, Michelle K, Kenny, Lizbeth, Chua, Benjamin, Keller, Jacqui, Edmunds, Jennifer, Pritchard, Wendy, Hay, Karen, Dunn, Darryl and Hughes, Brett G.M (2026). A prospective study of definitive ChemoRadiation with ImmunOtherapy (CRIO) in locally or regionally advanced, unresectable cutaneous squamous cell carcinoma. Advances in Radiation Oncology, 11 (8) 102041, 102041-8. doi: 10.1016/j.adro.2026.102041 |
|
2026 Journal Article Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)Itchins, Malinda, Alexander, Marliese, Kao, Steven, Nagrial, Adnan, Brown, Lauren J., Bowyer, Samantha, Parakh, Sagun, Moore, Melissa, Kong, Benjamin Y., Yeo, Nicholas, Hughes, Brett G. M., Arulananda, Surein, Chin, Venessa, Warburton, Lydia, Khoo, Trisha, Mersiades, Antony J., Leigh, Lilian, Rogers, Jennifer, Pavlakis, Nick and Solomon, Benjamin J. (2026). Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1). Lung Cancer, 218 109500, 109500. doi: 10.1016/j.lungcan.2026.109500 |
|
2026 Journal Article Authors’ ResponsePunyadeera, Chamindie, Huang, Xiaomin, Balakittnen, Jaikrishna, Weeramange, Chameera Ekanayake, Vasani, Sarju, Wijesekera, Akila, Kenny, Lizbeth, Ladwa, Rahul and Hughes, Brett G.M. (2026). Authors’ Response. The Journal of the American Dental Association, 157 (9), 954-956. doi: 10.1016/j.adaj.2026.06.017 |
|
2026 Journal Article Salivary oral rinse offers a noninvasive method to detect oral human papillomavirus infections on the GeneXpert systemHuang, Xiaomin, Balakittnen, Jaikrishna, Weeramange, Chameera Ekanayake, Vasani, Sarju, Wijesekera, Akila, Kenny, Lizbeth, Ladwa, Rahul, Hughes, Brett G.M. and Punyadeera, Chamindie (2026). Salivary oral rinse offers a noninvasive method to detect oral human papillomavirus infections on the GeneXpert system. Journal of the American Dental Association, 157 (5), 448-458. doi: 10.1016/j.adaj.2026.02.013 |
|
2026 Journal Article Defining the tumor microenvironment of non‐small cell lung cancerEmbaye, Kidane Siele, Blick, Tony, Naei, Vahid Yaghoubi, O'Byrne, Ken, Hughes, Brett G. M. and Kulasinghe, Arutha (2026). Defining the tumor microenvironment of non‐small cell lung cancer. Immunology and Cell Biology, 104 (5) imcb.70114, 499-518. doi: 10.1111/imcb.70114 |
|
2026 Journal Article Clinical outcomes of the POPCORN Study: pharmacodynamics of pre-operative PD1 CheckpOint blockade and Receptor Activator of NF-κB Ligand (RANKL) inhibition in Non-Small Cell Lung Cancer (NSCLC)-a phase 1B/2 TrialAhern, Elizabeth, Turner, Cassie, Naidoo, Rishendran, Godbolt, David, Ives, Amy, Popplewell, Kirsten, Lwin, Zarnie, Pearson, Sally, Nelson, Kimberley, Madore, Jason, Dougall, William C. and Hughes, Brett G. M. (2026). Clinical outcomes of the POPCORN Study: pharmacodynamics of pre-operative PD1 CheckpOint blockade and Receptor Activator of NF-κB Ligand (RANKL) inhibition in Non-Small Cell Lung Cancer (NSCLC)-a phase 1B/2 Trial. Asia-Pacific Journal of Clinical Oncology ajco.70107. doi: 10.1111/ajco.70107 |
|
2026 Journal Article Erratum: Correction to: Circulating tumour cells and circulating tumour DNA in head and neck cancer: from molecular insights to clinical impact (Cancer metastasis reviews (2025) 44 4 PII: 24 DOI: 10.1007/s10555-025-10305-y.)Damodaran, Sreedevi, Weeramange, Chameera Ekanayake, Kenny, Lizbeth, Vasani, Sarju, Hughes, Brett G M, Breik, Omar and Punyadeera, Chamindie (2026). Erratum: Correction to: Circulating tumour cells and circulating tumour DNA in head and neck cancer: from molecular insights to clinical impact (Cancer metastasis reviews (2025) 44 4 PII: 24 DOI: 10.1007/s10555-025-10305-y.). Cancer metastasis reviews, 45 (2) 24. doi: 10.1007/s10555-026-10329-y |
|
2026 Journal Article Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort studyBennett, Catherine, McLean, Luke S., Lim, Annette M., Bressel, Mathias, Guminski, Alexander, Hughes, Brett G.M., Bowyer, Samantha E., Stein, Brian and Rischin, Danny (2026). Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study. Journal of the American Academy of Dermatology, 94 (4), 1151-1157. doi: 10.1016/j.jaad.2025.11.080 |
|
2025 Journal Article Comparison of prophylactic versus reactive tube feeding approaches on weight loss and unplanned hospital admissions in patients with head and neck cancer receiving chemoradiotherapyBrown, Teresa, Cooney, Louise, Smith, David, Elvin-Walsh, Louise, Kern, Eliza, Ahern, Suzanne, Brown, Bena, Hickman, Ingrid, Porceddu, Sandro, Kenny, Lizbeth and Hughes, Brett (2025). Comparison of prophylactic versus reactive tube feeding approaches on weight loss and unplanned hospital admissions in patients with head and neck cancer receiving chemoradiotherapy. Current Oncology, 33 (1) 5. doi: 10.3390/curroncol33010005 |
|
2025 Journal Article Circulating tumour cells and circulating tumour DNA in head and neck cancer: from molecular insights to clinical impactDamodaran, Sreedevi, Weeramange, Chameera Ekanayake, Kenny, Lizbeth, Vasani, Sarju, Hughes, Brett G. M., Breik, Omar and Punyadeera, Chamindie (2025). Circulating tumour cells and circulating tumour DNA in head and neck cancer: from molecular insights to clinical impact. Cancer and Metastasis Reviews, 44 (4) 88, 1-28. doi: 10.1007/s10555-025-10305-y |
|
2025 Journal Article Development of a circulating tumour cell culture model from head and neck squamous cell carcinomaHuang, Xiaomin, Zhang, Xi, Weeramange, Chameera Ekanayake, Leo, Paul, Hughes, Brett G. M., Dolcetti, Riccardo, Zeng, Bijun, Mazzieri, Roberta, Hartel, Gunter, Ladwa, Rahul, Taheri, Touraj, Breik, Omar, Kenny, Lizbeth, Vasani, Sarju and Punyadeera, Chamindie (2025). Development of a circulating tumour cell culture model from head and neck squamous cell carcinoma. View, 6 (6) 20250085, 1-13. doi: 10.1002/VIW.20250085 |
|
2025 Journal Article Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysisAlexander, Marliese, Itchins, Malinda, Felthun, Jonathan, Nagrial, Adnan, Brown, Lauren J., O'Byrne, Kenneth, Mersiades, Antony J., Hughes, Brett G.M., Warburton, Lydia, Kong, Benjamin Y., Moore, Melissa, Blinman, Prunella, Bowyer, Samantha, Clay, Timothy, Spelman, Tim, Pavlakis, Nick, Solomon, Benjamin J. and Kao, Steven (2025). Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis. Lung Cancer, 211 108854. doi: 10.1016/j.lungcan.2025.108854 |
|
2025 Journal Article Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancerAndreas, V., Faltys, M., Alexander, M., Rogers, J., Parakh, S., Bowyer, S., Warburton, L., Fantoni, A., Clay, T., Arulananda, S., Sullivan, I., Kao, S., Da Silva, I., Brown, L. J., Hughes, B. G. M., Itchins, M., Solomon, B. and John, T. (2025). Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancer. Lung Cancer, 209 108786. doi: 10.1016/j.lungcan.2025.108786 |
|
2025 Journal Article Tumour-informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post-treatmentHuang, Xiaomin, Leo, Paul, Clout, Mhairi, Fink, Lynn, Ellis, Jonathan, Hughes, Brett G. M., Kenny, Lizbeth, Vasani, Sarju and Punyadeera, Chamindie (2025). Tumour-informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post-treatment. VIEW, 7 (2) 20250112, 1-13. doi: 10.1002/VIW.20250112 |
|
2025 Journal Article Response-adapted surgical and radiotherapy de-escalation in resectable cutaneous squamous cell cancer using pembrolizumab: the De-Squamate studyLadwa, Rahul, Lee, Jenny H., McGrath, Margaret, Cooper, Caroline, Liu, Howard, Bowman, James, Gupta, Ruta, Cuscaden, Claire, Nottage, Michelle, Clark, Jonathan R., Le, Dieu, Pauley, Marketa, Kulasinghe, Arutha, Gonzalez-Cruz, Jazmina, Porceddu, Sandro V., Hughes, Brett G.M. and Panizza, Benedict (2025). Response-adapted surgical and radiotherapy de-escalation in resectable cutaneous squamous cell cancer using pembrolizumab: the De-Squamate study. Journal of Clinical Oncology, 43 (26) JCO-25-00387, 2888-2896. doi: 10.1200/jco-25-00387 |
